TEVA @ MASCC provides an ideal opportunity to introduce Teva as a pharmaceutical solutions provider in onco… | Experiential marketing, Booth design, Branding design
2013 09 25_ildiko_innovation at teva
Color Defining Health Care Exhibit - kubik
Color Defining Health Care Exhibit - kubik
Ignyta acquires Teva's upcoming oncology program at $41.6 mn
Intas Pharmaceuticals: Intas eyes Teva's oncology, women's health divisions in Europe - The Economic Times
Teva Announces tomy's Award Winner at Oncology Satellite Symposium During the 7th International Symposium on Acute Promyelocytic Leukemia (APL) in Rome, Italy | Business Wire
Exhibit EX-99.1
Country Onco Overview ARGENTINA - ppt video online download
Teva concludes $703m women's health products deal with CVC Capital - Pharmaceutical Technology
Generic NSCLC treatment launched by Teva
Teva's Cancer Injection Drug Approved by FDA - Drug Discovery and Development
Color Defining Health Care Exhibit - kubik
Teva secures FDA approval for Ajovy to prevent migraine episodes
TEVA Oncology Campaign | Clios
TEVA Oncology Campaign | Clios
Teva Reports Fourth Quarter and Full Year 2020 Financial Results | Business Wire
Teva extends global rebrand with tailored marketing messages for caregivers | Fierce Pharma
CSRWire - International Childhood Cancer Day Announcement: Global Hope, Teva and Direct Relief Partner to Bring Medicines to Help Improve the Lives of Children With Cancer in Africa
Intas Pharmaceuticals: Intas eyes Teva's oncology, women's health divisions in Europe - The Economic Times
Teva Announces New Brand Positioning and Visual Identity in North America